124 related articles for article (PubMed ID: 29061220)
1. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
Qin B; Jiao X; Yuan L; Liu K; Zang Y
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
[TBL] [Abstract][Full Text] [Related]
2. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
[TBL] [Abstract][Full Text] [Related]
3. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy.
Zhuang YP; Zhu YP; Wang HY; Sun L; Zhang J; Hao YP; Wang L
Braz J Med Biol Res; 2017 May; 50(6):e6000. PubMed ID: 28538836
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a non-small-cell lung cancer-liver metastasis patient-derived tumor xenograft model for the evaluation of patient-tailored chemotherapy.
Yang X; Meng G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221816
[TBL] [Abstract][Full Text] [Related]
5. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
Gandara DR; Mack PC; Bult C; Li T; Lara PN; Riess JW; Astrow SH; Gandour-Edwards R; Cooke DT; Yoneda KY; Moore EH; Pan CX; Burich RA; David EA; Keck JG; Airhart S; Goodwin N; de Vere White RW; Liu ET
Clin Lung Cancer; 2015 May; 16(3):165-72. PubMed ID: 25838158
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived tumor xenograft models for melanoma drug discovery.
Harris AL; Joseph RW; Copland JA
Expert Opin Drug Discov; 2016 Sep; 11(9):895-906. PubMed ID: 27454070
[TBL] [Abstract][Full Text] [Related]
7. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD
J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591
[TBL] [Abstract][Full Text] [Related]
8. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
[TBL] [Abstract][Full Text] [Related]
9. Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.
Bagby S; Messersmith WA; Pitts TM; Capasso A; Varella-Garcia M; Klauck PJ; Kim J; Tan AC; Eckhardt SG; Tentler JJ; Arcaroli J
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768028
[TBL] [Abstract][Full Text] [Related]
10. Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models.
Yang CY; Lin CK; Tsao CH; Hsieh CC; Lin GJ; Ma KH; Shieh YS; Sytwu HK; Chen YW
Oncotarget; 2017 May; 8(20):33756-33769. PubMed ID: 28422711
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma.
Qassemyar A; Gabert PE; Kluza J; Duquennoy-Martinot V; Mortier L; Marchetti P; Guerreschi P
Melanoma Res; 2016 Jun; 26(3):245-53. PubMed ID: 26983079
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.
Zhu Y; Tian T; Li Z; Tang Z; Wang L; Wu J; Li Y; Dong B; Li Y; Li N; Zou J; Gao J; Shen L
Sci Rep; 2015 Feb; 5():8542. PubMed ID: 25712750
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma.
Guerreschi P; Scalbert C; Qassemyar A; Kluza J; Ravasi L; Huglo D; Martinot-Duquennoy V; Formstecher P; Marchetti P; Mortier L
Melanoma Res; 2013 Oct; 23(5):373-80. PubMed ID: 23852164
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived tumour xenografts for breast cancer drug discovery.
Cassidy JW; Batra AS; Greenwood W; Bruna A
Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
16. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery.
Cacciapuoti MT; Cappelli LV; Fiore D; Toruno P; Kayembe C; Tam W; Inghirami G
Curr Protoc; 2021 Apr; 1(4):e96. PubMed ID: 33861502
[TBL] [Abstract][Full Text] [Related]
17. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
[TBL] [Abstract][Full Text] [Related]
18. Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology.
Calles A; Rubio-Viqueira B; Hidalgo M
Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.26. PubMed ID: 23744711
[TBL] [Abstract][Full Text] [Related]
19. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer.
Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L
J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174
[TBL] [Abstract][Full Text] [Related]
20. A Preliminary Study on the Establishment of the PDTX Model.
Liu Y; Zhu YP; Cai MZ; Ke B; Li B; Liu N; Xue Q; Zhan HJ; Deng JY; Zhang L; Hao YP; Wang ZQ; Wang L; Liang H
Cancer Manag Res; 2020; 12():1969-1979. PubMed ID: 32256107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
